Feasibility of a Mobile Medication Plan Application in CF Patient Care

Inclusion Criteria:

- CLINICIAN PARTICIPANTS:

1. A CF care team member from any discipline, designated by the site principal
investigator (PI) and CF team

2. Willing to use MAP as part of CF care

- PATIENT PARTICIPANTS:

1. Male or female patients ages ≥ 12 years of age at Study Visit 1

2. Documentation of a CF diagnosis (physician diagnosed)

3. Ability to understand verbal and written English

4. Access to mobile device such as a tablet or smartphone (iPhone/iPad/iTouch or
Android device)

5. Willingness to use the MAP application

6. Currently taking at least one of the following chronic medications and willing to
use AdhereTech pill bottles for oral medications and/or eTrack nebulizer for
nebulized medications listed below: nebulized agents, dornase alfa, hypertonic
saline, inhaled tobramycin, inhaled aztreonam, inhaled colistimethate, oral
agents, azithromycin

- CAREGIVER PARTICIPANTS (for Patient Participants age < 18 years)

1. Child is consented to participate in the study.

2. Ability to understand verbal and written English

Exclusion Criteria:

- CLINICIAN PARTICIPANTS:

Previous use of MAP (with patient(s) or self) in the last 12 months - when used with
patients, defined as use in 5 or more patients

- PATIENT PARTICIPANTS:

1. Previous use of MAP in the last 12 months - defined as use for 4 weeks or longer
in own care

2. Presence of a condition or abnormality that in the opinion of the Investigator
would compromise the safety of the patient or the quality of the data including,
but not limited to, diagnosis of intellectual or developmental disability (e.g.,
autism); and/or history of lung transplant

3. Planned or scheduled hospitalization during study period of up to 36 weeks

- CAREGIVER PARTICIPANTS:

(for Patient Participants age < 18 years)

1. Previous use of MAP in the last 12 months - defined as use for 4 weeks or longer in
child's or own care